Using cerebrospinal fluid from living patients, researchers have identified specific proteins and genetic pathways involved in the development and progression of Alzheimer’s disease. This proteomic analysis revealed 38 proteins likely to play causal roles in Alzheimer’s, 15 of which are potential drug targets.